Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

A Monoclonal Antibody against 6-Acetylmorphine Protects Female Mice Offspring from Adverse Behavioral Effects Induced by Prenatal Heroin Exposure.

Kvello AMS, Andersen JM, Øiestad EL, Steinsland S, Aase A, Mørland J, Bogen IL.

J Pharmacol Exp Ther. 2019 Jan;368(1):106-115. doi: 10.1124/jpet.118.251504. Epub 2018 Oct 25.

PMID:
30361238
2.

Are the current notification criteria for Lyme borreliosis in Norway suitable? Results of an evaluation of Lyme borreliosis surveillance in Norway, 1995-2013.

MacDonald E, Vestrheim DF, White RA, Konsmo K, Lange H, Aase A, Nygård K, Stefanoff P, Aaberge I, Vold L.

BMC Public Health. 2016 Aug 5;16:729. doi: 10.1186/s12889-016-3346-9.

3.

Validate or falsify: Lessons learned from a microscopy method claimed to be useful for detecting Borrelia and Babesia organisms in human blood.

Aase A, Hajdusek O, Øines Ø, Quarsten H, Wilhelmsson P, Herstad TK, Kjelland V, Sima R, Jalovecka M, Lindgren PE, Aaberge IS.

Infect Dis (Lond). 2016;48(6):411-9. doi: 10.3109/23744235.2016.1144931. Epub 2016 Feb 23.

PMID:
27030913
4.

Geographical differences in seroprevalence of Borrelia burgdorferi antibodies in Norway, 2011-2013.

Vestrheim DF, White RA, Aaberge IS, Aase A.

Ticks Tick Borne Dis. 2016 Jul;7(5):698-702. doi: 10.1016/j.ttbdis.2016.02.020. Epub 2016 Feb 27.

PMID:
26961275
5.

Cellular Immune Responses in Humans Induced by Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines Given Separately and in Combination.

Oftung F, Korsvold GE, Aase A, Næss LM.

Clin Vaccine Immunol. 2016 Apr 4;23(4):353-62. doi: 10.1128/CVI.00666-15. Print 2016 Apr.

6.

Etiology of Pneumonia in a Pediatric Population with High Pneumococcal Vaccine Coverage: A Prospective Study.

Berg AS, Inchley CS, Aase A, Fjaerli HO, Bull R, Aaberge I, Leegaard TM, Nakstad B.

Pediatr Infect Dis J. 2016 Mar;35(3):e69-75. doi: 10.1097/INF.0000000000001009.

PMID:
26599568
7.

Salivary IgA from the sublingual compartment as a novel noninvasive proxy for intestinal immune induction.

Aase A, Sommerfelt H, Petersen LB, Bolstad M, Cox RJ, Langeland N, Guttormsen AB, Steinsland H, Skrede S, Brandtzaeg P.

Mucosal Immunol. 2016 Jul;9(4):884-93. doi: 10.1038/mi.2015.107. Epub 2015 Oct 28.

PMID:
26509875
8.

Weight development from age 13 to 30 years and adolescent socioeconomic status: The Norwegian Longitudinal Health Behaviour study.

Bergh IH, Skare Ø, Aase A, Klepp KI, Lien N.

Int J Public Health. 2016 May;61(4):465-73. doi: 10.1007/s00038-015-0748-x. Epub 2015 Oct 7.

9.

Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.

Grevys A, Bern M, Foss S, Bratlie DB, Moen A, Gunnarsen KS, Aase A, Michaelsen TE, Sandlie I, Andersen JT.

J Immunol. 2015 Jun 1;194(11):5497-508. doi: 10.4049/jimmunol.1401218. Epub 2015 Apr 22.

10.

Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.

Tunheim G, Naess LM, Acevedo R, Fjeldheim ÅK, Bolstad K, García L, Cardoso D, Aase A, Zayas C, González H, Rosenqvist E, Norheim G.

Vaccine. 2014 Nov 20;32(49):6631-8. doi: 10.1016/j.vaccine.2014.09.063.

PMID:
25305564
11.

Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age.

Aase A, Herstad TK, Jørgensen SB, Leegaard TM, Berbers G, Steinbakk M, Aaberge I.

Vaccine. 2014 Oct 14;32(45):5931-6. doi: 10.1016/j.vaccine.2014.08.069. Epub 2014 Sep 13.

12.

Experimental infection of healthy volunteers with enterotoxigenic Escherichia coli wild-type strain TW10598 in a hospital ward.

Skrede S, Steinsland H, Sommerfelt H, Aase A, Brandtzaeg P, Langeland N, Cox RJ, Saevik M, Wallevik M, Skutlaberg DH, Tellevik MG, Sack DA, Nataro JP, Guttormsen AB.

BMC Infect Dis. 2014 Sep 4;14:482. doi: 10.1186/1471-2334-14-482.

13.

Demonstrating a new framework for the comparison of environmental impacts from small- and large-scale hydropower and wind power projects.

Bakken TH, Aase AG, Hagen D, Sundt H, Barton DN, Lujala P.

J Environ Manage. 2014 Jul 1;140:93-101. doi: 10.1016/j.jenvman.2014.01.050. Epub 2014 Apr 13.

14.

[Cellular Borrelia tests].

Tveten Y, Noraas S, Aase A.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):146-7. doi: 10.4045/tidsskr.13.1053. Norwegian. No abstract available.

15.

Human antibody responses to pneumococcal surface protein A and capsular polysaccharides during acute and convalescent stages of invasive disease in adult patients.

Kolberg J, Aase A, Naess LM, Aaberge IS, Caugant DA.

Pathog Dis. 2014 Feb;70(1):40-50. doi: 10.1111/2049-632X.12106. Epub 2013 Nov 21.

PMID:
24151210
16.

Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.

Tunheim G, Arnemo M, Næss LM, Fjeldheim ÅK, Nome L, Bolstad K, Aase A, Mandiarote A, González H, González D, García L, Cardoso D, Norheim G, Rosenqvist E.

Vaccine. 2013 Dec 9;31(51):6097-106. doi: 10.1016/j.vaccine.2013.09.044. Epub 2013 Oct 10.

PMID:
24120679
17.

Meningococcal omp85 in detergent-extracted outer membrane vesicle vaccines induces high levels of non-functional antibodies in mice.

Wedege E, Lie K, Bolstad K, Weynants VE, Halstensen A, Herstad TK, Kreutzberger J, Nome L, Naess LM, Aase A.

Scand J Immunol. 2013 Jun;77(6):452-9. doi: 10.1111/sji.12051.

18.

Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Aase A, Herstad TK, Merino S, Bolstad M, Sandbu S, Bakke H, Aaberge IS.

Clin Vaccine Immunol. 2011 Aug;18(8):1269-74. doi: 10.1128/CVI.05067-11. Epub 2011 Jun 15.

19.

Polyreactivity of monoclonal antibodies made against human erythrocyte membranes with various pathogenic bacteria.

Kolberg J, Ihle Ø, Thiede B, Aase A.

Hybridoma (Larchmt). 2011 Feb;30(1):1-9. doi: 10.1089/hyb.2010.0062.

PMID:
21466280
20.

Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.

Hellerud BC, Aase A, Herstad TK, Naess LM, Kristiansen LH, Trøseid AM, Harboe M, Lappegård KT, Brandtzaeg P, Høiby EA, Mollnes TE.

Infect Immun. 2010 Feb;78(2):802-9. doi: 10.1128/IAI.01044-09. Epub 2009 Nov 23.

21.

Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults.

Findlow H, Plikaytis BD, Aase A, Bash MC, Chadha H, Elie C, Laher G, Martinez J, Herstad T, Newton E, Viviani S, Papaspyridis C, Kulkarni P, Wilding M, Preziosi MP, Marchetti E, Hassan-King M, La Force FM, Carlone G, Borrow R.

Clin Vaccine Immunol. 2009 Jul;16(7):969-77. doi: 10.1128/CVI.00068-09. Epub 2009 May 27.

22.

The surface-associated elongation factor Tu is concealed for antibody binding on viable pneumococci and meningococci.

Kolberg J, Hammerschmidt S, Frank R, Jonák J, Sanderová H, Aase A.

FEMS Immunol Med Microbiol. 2008 Jul;53(2):222-30. doi: 10.1111/j.1574-695X.2008.00419.x. Epub 2008 May 5.

23.

Identification of genes particularly sensitive to lipopolysaccharide (LPS) in human monocytes induced by wild-type versus LPS-deficient Neisseria meningitidis strains.

Ovstebø R, Olstad OK, Brusletto B, Møller AS, Aase A, Haug KB, Brandtzaeg P, Kierulf P.

Infect Immun. 2008 Jun;76(6):2685-95. doi: 10.1128/IAI.01625-07. Epub 2008 Mar 24.

24.

Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines.

Sandbu S, Feiring B, Oster P, Helland OS, Bakke HS, Naess LM, Aase A, Aaberge IS, Kristoffersen AC, Rydland KM, Tilman S, Nøkleby H, Rosenqvist E.

Clin Vaccine Immunol. 2007 Sep;14(9):1062-9. Epub 2007 Jul 18.

25.

Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Aase A, Herstad TK, Merino S, Brandsdal KT, Berdal BP, Aleksandersen EM, Aaberge IS.

Clin Vaccine Immunol. 2007 Jul;14(7):855-62. Epub 2007 May 16.

26.

Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.

Wedege E, Bolstad K, Aase A, Herstad TK, McCallum L, Rosenqvist E, Oster P, Martin D.

Clin Vaccine Immunol. 2007 Jul;14(7):830-8. Epub 2007 May 9.

27.

Children, AIDS and the politics of orphan care in Ethiopia: the extended family revisited.

Abebe T, Aase A.

Soc Sci Med. 2007 May;64(10):2058-69. Epub 2007 Mar 26.

PMID:
17379371
28.

Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.

Findlow J, Taylor S, Aase A, Horton R, Heyderman R, Southern J, Andrews N, Barchha R, Harrison E, Lowe A, Boxer E, Heaton C, Balmer P, Kaczmarski E, Oster P, Gorringe A, Borrow R, Miller E.

Infect Immun. 2006 Aug;74(8):4557-65. Erratum in: Infect Immun. 2007 Aug;75(8):4187.

29.

Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface.

Kolberg J, Aase A, Bergmann S, Herstad TK, Rødal G, Frank R, Rohde M, Hammerschmidt S.

Microbiology. 2006 May;152(Pt 5):1307-17.

PMID:
16622048
30.

Social reversal of immunosenescence in honey bee workers.

Amdam GV, Aase AL, Seehuus SC, Kim Fondrk M, Norberg K, Hartfelder K.

Exp Gerontol. 2005 Dec;40(12):939-47. Epub 2005 Oct 5.

31.
32.
33.

Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.

Norheim G, Aase A, Caugant DA, Høiby EA, Fritzsønn E, Tangen T, Kristiansen P, Heggelund U, Rosenqvist E.

Vaccine. 2005 May 31;23(29):3762-74. Epub 2005 Mar 14.

PMID:
15893613
34.

Ambient air particles from four European cities increase the primary cellular response to allergen in the draining lymph node.

Nygaard UC, Alberg T, Bleumink R, Aase A, Dybing E, Pieters R, Løvik M.

Toxicology. 2005 Feb 14;207(2):241-54.

PMID:
15596255
35.

The IgE adjuvant effect of particles: characterisation of the primary cellular response in the draining lymph node.

Nygaard UC, Ormstad H, Aase A, Løvik M.

Toxicology. 2005 Jan 15;206(2):181-93.

PMID:
15588912
36.

The capacity of particles to increase allergic sensitization is predicted by particle number and surface area, not by particle mass.

Nygaard UC, Samuelsen M, Aase A, Løvik M.

Toxicol Sci. 2004 Dec;82(2):515-24. Epub 2004 Sep 29.

PMID:
15456925
38.

Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modelling.

Kolberg J, Aase A, Rødal G, Littlejohn JE, Jedrzejas MJ.

FEMS Immunol Med Microbiol. 2003 Dec 5;39(3):265-73.

39.

Binding properties and anti-bacterial activities of V-region identical, human IgG and IgM antibodies, against group B Neisseria meningitidis.

Michaelsen TE, Ihle Ø, Beckstrøm KJ, Herstad TK, Sandin RH, Kolberg J, Aase A.

Biochem Soc Trans. 2003 Oct;31(Pt 5):1032-5.

PMID:
14505474
40.
41.

Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.

Sprong T, Brandtzaeg P, Fung M, Pharo AM, Høiby EA, Michaelsen TE, Aase A, van der Meer JW, van Deuren M, Mollnes TE.

Blood. 2003 Nov 15;102(10):3702-10. Epub 2003 Jul 24.

42.

Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease.

Aase A, Naess LM, Sandin RH, Herstad TK, Oftung F, Holst J, Haugen IL, Høiby EA, Michaelsen TE.

Vaccine. 2003 May 16;21(17-18):2042-51.

PMID:
12706694
43.

Epitope analyses of pneumococcal surface protein A: a combination of two monoclonal antibodies detects 94% of clinical isolates.

Kolberg J, Aase A, Michaelsen TE, Rødal G.

FEMS Immunol Med Microbiol. 2001 Oct;31(3):175-80.

44.

PorB3 outer membrane protein on Neisseria meningitidis is poorly accessible for antibody binding on live bacteria.

Michaelsen TE, Aase A, Kolberg J, Wedge E, Rosenqvist E.

Vaccine. 2001 Jan 8;19(11-12):1526-33.

PMID:
11163678
45.

T-cell responses against meningococcal antigens.

Næss LM, Oftung F, Aase A, Michaelsen TE, Pollard AJ.

Methods Mol Med. 2001;66:339-48. doi: 10.1385/1-59259-148-5:339.

PMID:
21336766
46.

Antibody-induced opsonophagocytosis of serogroup B meningococci measured by flow cytometry.

Michaelsen TE, Aase A.

Methods Mol Med. 2001;66:331-7. doi: 10.1385/1-59259-148-5:331.

PMID:
21336765
47.

Streptococcus pneumoniae heat shock protein 70 does not induce human antibody responses during infection.

Kolberg J, Høiby EA, Aase A, Sletten K, Rødal G, Michaelsen TE, Bucher A.

FEMS Immunol Med Microbiol. 2000 Dec;29(4):289-94.

48.

Mechanism for uptake of silica particles by monocytic U937 cells.

Hetland G, Namork E, Schwarze PE, Aase A.

Hum Exp Toxicol. 2000 Jul;19(7):412-9.

PMID:
11002391
49.
50.

Supplemental Content

Support Center